Print PDF
Pfizer, Actavis End Patent Fight Over Generic Lipitor
October 12, 2011
IP Law360
The Law360 article, Pfizer, Actavis End Patent Fight Over Generic Lipitor, covered Cantor Colburn representation of Actavis. A Delaware federal judge on Tuesday dismissed pharmaceutical giant Pfizer Inc.’s patent infringement suit against Iceland-based Actavis Group HF over a generic version of anti-cholesterol drug Lipitor, after the parties announced they had reached a settlement. Cantor Colburn's Litigation Practice Group has a specialty practice in Pharmaceutical Patent Litigation.
